Sergio Salazar‐Marioni

Texas Oncology

Papers

1

Total Citations

63

H-Index

1

About

Dr. Sergio Salazar‐Marioni is a leading figure in gynecologic oncology, whose work has significantly advanced the surgical management of early-stage cervical cancer. His primary research focuses on the application of sentinel lymph node mapping to reduce surgical morbidity while maintaining oncologic safety. In his most cited paper, "Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer" (2016, 63 citations), Dr. Salazar‐Marioni demonstrated the high detection rates and feasibility of indocyanine green as a tracer, providing a critical evidence base for a less invasive alternative to traditional lymphadenectomy. This contribution has helped shape current clinical guidelines, offering patients a more precise, lower-risk approach to staging. Beyond this landmark study, his broader work encompasses the optimization of minimally invasive techniques and the integration of novel imaging modalities in gynecologic cancer care. With a career dedicated to translating innovative surgical strategies into tangible patient benefits, Dr. Salazar‐Marioni’s research continues to influence practice patterns and inspire further investigation into personalized, de-escalated treatment pathways for women with cervical cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
63
Total Citations
63
Avg Citations/Paper
🏆 Most Cited Paper
Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer
63 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Texas Oncology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago